Teza Capital Management LLC Purchases New Position in Bath & Body Works, Inc. (NYSE:BBWI)

Teza Capital Management LLC acquired a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 8,675 shares of the company’s stock, valued at approximately $336,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Golden State Wealth Management LLC acquired a new position in shares of Bath & Body Works during the 4th quarter valued at about $26,000. SRS Capital Advisors Inc. boosted its position in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after purchasing an additional 329 shares during the period. UMB Bank n.a. grew its holdings in Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after purchasing an additional 335 shares during the last quarter. Lindbrook Capital LLC raised its position in shares of Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after purchasing an additional 431 shares during the period. Finally, Smartleaf Asset Management LLC raised its position in shares of Bath & Body Works by 135.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company’s stock valued at $39,000 after purchasing an additional 582 shares during the period. Institutional investors own 95.14% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on BBWI. Robert W. Baird upped their price objective on shares of Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a report on Friday, February 28th. Barclays upped their price target on shares of Bath & Body Works from $31.00 to $35.00 and gave the company an “equal weight” rating in a report on Tuesday. Morgan Stanley dropped their price objective on Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 6th. UBS Group boosted their price objective on Bath & Body Works from $32.00 to $36.00 and gave the stock a “neutral” rating in a research report on Tuesday. Finally, Raymond James lowered their target price on Bath & Body Works from $46.00 to $37.00 and set an “outperform” rating on the stock in a report on Thursday, April 17th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $42.56.

Read Our Latest Stock Report on BBWI

Bath & Body Works Trading Down 0.4%

Shares of NYSE:BBWI opened at $33.43 on Wednesday. The business’s 50 day moving average is $30.16 and its 200-day moving average is $34.03. The firm has a market capitalization of $7.12 billion, a PE ratio of 8.15, a PEG ratio of 0.92 and a beta of 1.87. Bath & Body Works, Inc. has a 1-year low of $24.96 and a 1-year high of $52.99.

Bath & Body Works (NYSE:BBWIGet Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. On average, sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works announced that its board has authorized a share repurchase plan on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its shares are undervalued.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be paid a $0.20 dividend. The ex-dividend date is Friday, June 6th. This represents a $0.80 dividend on an annualized basis and a yield of 2.39%. Bath & Body Works’s payout ratio is currently 21.98%.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Featured Articles

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.